Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer

by Miles, D W, de Haas, S L, Dirix, L Y, Romieu, G, Chan, A, Pivot, X, Tomczak, P, Provencher, L, Cortés, J, Delmar, P R, Scherer, S J
Published 2013

Organisational design for an integrated oncological department

by Meiss-de Haas, Ch.L., Falkmann, H., Douma, J., van Gassel, J.G., Peters, W.G., van Mierlo, R., van Turnhout, J.M., Verhagen, C.A.H.H.V.M., Schrijvers, A.J.P.
Published 2001